These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30635088)

  • 41. BAG2 structure, function and involvement in disease.
    Qin L; Guo J; Zheng Q; Zhang H
    Cell Mol Biol Lett; 2016; 21():18. PubMed ID: 28536620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polyglutamine diseases and molecular chaperones.
    Kimura Y; Kakizuka A
    IUBMB Life; 2003 Jun; 55(6):337-45. PubMed ID: 12938736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders.
    Janssen FJ; van der Stelt M
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3831-7. PubMed ID: 27394666
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of chaperones in polyglutamine disease.
    Opal P; Zoghbi HY
    Trends Mol Med; 2002 May; 8(5):232-6. PubMed ID: 12067633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting JNK for therapeutic benefit: from junk to gold?
    Manning AM; Davis RJ
    Nat Rev Drug Discov; 2003 Jul; 2(7):554-65. PubMed ID: 12815381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular chaperones as regulators of cell death.
    Hishiya A; Takayama S
    Oncogene; 2008 Oct; 27(50):6489-506. PubMed ID: 18955975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transautophagy: Research and Translation of Autophagy Knowledge.
    Albertini MC; Proikas-Cezanne T; Engedal N; Žerovnik E; Lane JD
    Oxid Med Cell Longev; 2018; 2018():7504165. PubMed ID: 29861835
    [No Abstract]   [Full Text] [Related]  

  • 48. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Steroid Receptor-Associated Immunophilins: Candidates for Diverse Drug-Targeting Approaches in Disease.
    Ratajczak T
    Curr Mol Pharmacol; 2015; 9(1):66-95. PubMed ID: 25986567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Special Issue: "Polyphenols and health".
    Morand C; Sies H
    Arch Biochem Biophys; 2016 Jun; 599():1-2. PubMed ID: 26997173
    [No Abstract]   [Full Text] [Related]  

  • 51. NADPH Oxidase-Derived ROS Signaling and Therapeutic Opportunities.
    Peshavariya H
    Curr Pharm Des; 2015; 21(41):5931-2. PubMed ID: 26537745
    [No Abstract]   [Full Text] [Related]  

  • 52. Therapeutic Development of Interrelated Metabolic and Neurodegenerative Disorders.
    Nguyen XT; Le L
    Curr Pharm Des; 2016; 22(23):3608-18. PubMed ID: 27093955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of molecular chaperones in human misfolding diseases.
    Broadley SA; Hartl FU
    FEBS Lett; 2009 Aug; 583(16):2647-53. PubMed ID: 19393652
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FGF21-based pharmacotherapy--potential utility for metabolic disorders.
    Gimeno RE; Moller DE
    Trends Endocrinol Metab; 2014 Jun; 25(6):303-11. PubMed ID: 24709036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ER chaperones in neurodegenerative disease: Folding and beyond.
    Garcia-Huerta P; Bargsted L; Rivas A; Matus S; Vidal RL
    Brain Res; 2016 Oct; 1648(Pt B):580-587. PubMed ID: 27134034
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current Evidence for a Role of Neuropeptides in the Regulation of Autophagy.
    Catalani E; De Palma C; Perrotta C; Cervia D
    Biomed Res Int; 2017; 2017():5856071. PubMed ID: 28593174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of neurodegeneration by molecular chaperones.
    Muchowski PJ; Wacker JL
    Nat Rev Neurosci; 2005 Jan; 6(1):11-22. PubMed ID: 15611723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective effect of chaperones on polyglutamine diseases.
    Kobayashi Y; Sobue G
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):165-8. PubMed ID: 11719246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?
    Muchowski PJ
    Neuron; 2002 Jul; 35(1):9-12. PubMed ID: 12123602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug targets for amyloidosis.
    Kolstoe SE; Wood SP
    Biochem Soc Trans; 2010 Apr; 38(2):466-70. PubMed ID: 20298204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.